Chronic Pain, Data, Media and Treatment

PA: Court orders release on medical cannabis data regarding, “how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment.”

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.

Data

Data Treatment Patients Chronic Pain

Czech Republic softens regulations on medical cannabis says media report

Cannabis Law Report

JANUARY 3, 2022

The Czech Republic legalized therapeutic cannabis for selected patients in 2015, and health insurance companies have been covering up to 90% of the cost of the treatment since 2020. According to official data cited by the Czech News Agency (CTK), the treatment helped improve the health condition and well-being of patients in 69% of cases.

Media

Media Chronic Pain Patients Treatment

Press Release: Delic Announces Medical Advisory Board, Demonstrates Psychedelic Wellness Company’s Commitment to Science

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development

Research and Development Treatment Media Medicine

Renewing Medical Marijuana Cards in Arkansas: All You Need to Know

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana

Marijuana Treatment Compliance Compliance

Press Release: Delic Completes Acquisition of Ketamine Wellness Centers (KWC), Becomes Largest Psychedelic Wellness Chain in United States

Cannabis Law Report

NOVEMBER 9, 2021

(“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced the official, completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”), becoming the largest chain of wellness centers providing ketamine treatments in the U.S.

Treatment

Treatment Therapy Media Access

MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan

Cannabis Law Report

SEPTEMBER 13, 2021

Positive data from this important study would significantly advance MYMD-1’s potential to become a blockbuster drug for inflammation and aging.”. Because it can cross the blood-brain barrier, MYMD-1 is also positioned to be a possible treatment for multiple sclerosis and other brain-related disorders. Media: media@mymd.com.

Clinical Trials

Clinical Trials Pharmaceutical Research and Development Therapy

FDA Warns Companies Allegedly Illegally Selling CBD and Delta-8 THC Products to Label and Brand More Carefully

Cannabis Law Report

MAY 6, 2022

The FDA’s warning letters tell the public that the FDA reads and reviews companies’ websites, labels, social media, and marketing language. The FDA evaluates sellers’ claims, graphics, and product descriptions – including products marketed for animals, information about food additives, and social media websites.

THC

THC CBD Media Food

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

Cannabis Law Report

JULY 24, 2019

1 We have also reviewed your social media websites at www.facebook.com/CuraleafHemp External Link Disclaimer and [link] External Link Disclaimer ; these websites direct consumers to your website, [link] External Link Disclaimer , to purchase your products. ADHD.”. • “The Benefits of CBD Oil for ADHD.

CBD

CBD Tincture Pets Chronic Pain

The AHRQ Wants to Learn About Cannabis and Kratom For Chronic Pain

Veriheal

JANUARY 4, 2021

In adults with chronic pain , what are the harms of Kratom or other plant-based substances for treatment of chronic pain? In adults with chronic pain, what are the harms of cannabinoids? In adults with chronic pain, what are the benefits of cannabinoids? A Statement from the AHRQ.

Chronic Pain

Chronic Pain Therapy Cannabinoids Treatment

Columbia Care Launches the UK’s Broadest Portfolio of Doseable Medical Cannabis Extract Vaporizer Pens; First Company to Manufacture Extract Vaporization Products in the UK

Cannabis Law Report

DECEMBER 14, 2021

There are 28 million people suffering from chronic pain in the UK and this range of formulations offers pain doctors the best and most comprehensive selection of cannabinoid treatment options for their patients. Media Lindsay Wilson. media@col-care.com. Investor Lee Ann Evans. Investor Relations.

Extraction

Extraction Patients Medicine Tincture

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. At the same time, the outlook on cannabis research data is largely positive. Background. Legalisation occurred in Australia in 2016.

Research and Development

Research and Development Medicine Access Media

Santé Cannabis and Spectrum Therapeutics Launch Transformative Medical Cannabis Training Program for Québec Healthcare Professionals

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool.

Programs

Programs Research and Development Education Treatment

Virpax Reports Successful Results of Toxicology and Pharmacokinetic Study for Epoladerm™

Cannabis Law Report

DECEMBER 8, 2021

Single-dose transdermal delivery of Epoladerm was well-tolerated in all minipigs and no treatment-related clinical observations, changes in body weight, or dermal irritation were observed. This data should strengthen the Company’s IND filing in advance of the anticipated start of first-in-human clinical trials. Media: Laura Radocaj.

Clinical Trials

Clinical Trials Chronic Pain Pharmaceutical Topical

Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain

Cannabis Law Report

SEPTEMBER 1, 2022

AUSTIN, Texas, August 31, 2022 –( BUSINESS WIRE )–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). 1 reason patients seek medical cannabis is to augment their pain management treatment.

Chronic Pain

Chronic Pain Programs Patients Conditions

Santé Cannabis and Spectrum Therapeutics Launch Transformative Medical Cannabis Training Program

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. “It is our duty as physicians to understand the available treatment options for our patients, and medical cannabis treatments have emerged as an important clinical tool.

Programs

Programs Research and Development Education Treatment

Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain

Cannabis Law Report

AUGUST 31, 2022

AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). Chronic pain is one of the most prevalent and provable conditions that medical cannabis can positively impact.

Chronic Pain

Chronic Pain Programs Patients Conditions

Cannabis and traumatic brain injury, with Nikki Lawley

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. NL: I wish I had a healthcare provider help me. Honestly, it was trial and error.

Patients

Patients Compliance Compliance Cannabis

Medical Cannabis Brief

PA: Court orders release on medical cannabis data regarding, “how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment.”

Czech Republic softens regulations on medical cannabis says media report

Trending Sources

Press Release: Delic Announces Medical Advisory Board, Demonstrates Psychedelic Wellness Company’s Commitment to Science

Renewing Medical Marijuana Cards in Arkansas: All You Need to Know

Press Release: Delic Completes Acquisition of Ketamine Wellness Centers (KWC), Becomes Largest Psychedelic Wellness Chain in United States

MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan

FDA Warns Companies Allegedly Illegally Selling CBD and Delta-8 THC Products to Label and Brand More Carefully

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

The AHRQ Wants to Learn About Cannabis and Kratom For Chronic Pain

Columbia Care Launches the UK’s Broadest Portfolio of Doseable Medical Cannabis Extract Vaporizer Pens; First Company to Manufacture Extract Vaporization Products in the UK

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Santé Cannabis and Spectrum Therapeutics Launch Transformative Medical Cannabis Training Program for Québec Healthcare Professionals

Virpax Reports Successful Results of Toxicology and Pharmacokinetic Study for Epoladerm™

Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain

Santé Cannabis and Spectrum Therapeutics Launch Transformative Medical Cannabis Training Program

Texas Original Advocates To Expand Compassionate Use Program To Include Chronic Pain

Cannabis and traumatic brain injury, with Nikki Lawley

Stay Connected